No connection

Search Results

CAMP vs SLGL

CAMP
CAMP4 THERAPEUTICS CORPORATION
BEARISH
Price
$4.65
Market Cap
$241.4M
Sector
Healthcare
AI Confidence
60%
SLGL
Sol-Gel Technologies Ltd.
BEARISH
Price
$73.87
Market Cap
$239.7M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
CAMP
--
SLGL
--
Forward P/E
CAMP
-6.58
SLGL
-10.85
P/B Ratio
CAMP
5.06
SLGL
9.02
P/S Ratio
CAMP
69.02
SLGL
12.36
EV/EBITDA
CAMP
-2.49
SLGL
-24.66

Profitability

Gross Margin
CAMP
0.0%
SLGL
-17.62%
Operating Margin
CAMP
-3671.26%
SLGL
-497.84%
Profit Margin
CAMP
0.0%
SLGL
-31.6%
ROE
CAMP
-145.07%
SLGL
-23.72%
ROA
CAMP
-33.18%
SLGL
-14.43%

Growth

Revenue Growth
CAMP
-46.6%
SLGL
150.4%
Earnings Growth
CAMP
--
SLGL
--

Financial Health

Debt/Equity
CAMP
0.04
SLGL
0.04
Current Ratio
CAMP
7.35
SLGL
4.37
Quick Ratio
CAMP
7.07
SLGL
4.21

Dividends

Dividend Yield
CAMP
--
SLGL
--
Payout Ratio
CAMP
0.0%
SLGL
0.0%

AI Verdict

CAMP BEARISH

CAMP shows bearish fundamentals based on deterministic rules. Financial strength is weak (F-Score 1/9). Concerns include weak profitability or high valuation.

Strengths
Low debt with D/E ratio of 0.04
Risks
Weak financial trend (Piotroski F-Score: 1/9)
Declining revenue (-46.6%)
Weak ROE of -145.1%
SLGL BEARISH

SLGL exhibits a critical disconnect between its explosive 1-year price appreciation (+1243%) and its deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While revenue growth is exceptional at 150%, the company suffers from negative gross margins (-17.62%) and a catastrophic operating margin (-497.84%), indicating that the cost of producing its goods exceeds its sales revenue. Despite a strong liquidity position (Current Ratio 4.37) and low debt, the valuation is speculative with a Price/Book of 9.02 and a Price/Sales of 12.36. The stock is currently trading on growth momentum rather than financial viability.

Strengths
Explosive YoY revenue growth of 150.40%
Very low leverage with a Debt/Equity ratio of 0.04
Strong short-term liquidity (Current Ratio 4.37)
Risks
Negative gross margins indicate a non-viable cost structure
Severe operational inefficiency (Operating Margin -497.84%)
Extremely low Piotroski F-Score (2/9) signaling financial weakness

Compare Another Pair

CAMP vs SLGL: Head-to-Head Comparison

This page compares CAMP4 THERAPEUTICS CORPORATION (CAMP) and Sol-Gel Technologies Ltd. (SLGL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile